Navigation Links
VIA Pharmaceuticals to Present at Cowen and Company 28th Annual Health Care Conference
Date:3/11/2008

SAN FRANCISCO, March 11 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals (Nasdaq: VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease, announced today that Lawrence Cohen PhD, chief executive officer, and James G. Stewart, senior vice president and chief financial officer, will present a company update at the 2008 Cowen and Company 28th Annual Health Care Conference on Tuesday, March 18, 2008 at 1:40 p.m. ET at the Boston Copley Marriott Place Hotel in Boston.

Interested parties may access a live audio webcast of the presentation from the investor section of the VIA website, http://www.viapharmaceuticals.com. A replay of the presentation will be archived on the site for at least one week following the presentation.

About VIA Pharmaceuticals, Inc.

VIA Pharmaceuticals, Inc. is a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease. VIA is building a pipeline of small-molecule drugs that target a significant unmet medical need: reducing inflammation in the blood vessel wall, which is an underlying cause of atherosclerosis and its complications, including heart attack and stroke. The company's lead drug candidate, VIA-2291, is in multiple Phase 2 clinical studies in patients with cardiovascular disease. For more information, visit: http://www.viapharmaceuticals.com.


'/>"/>
SOURCE VIA Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... (PRWEB) July 31, 2014 Food ... are increasingly searching for food alternatives that offer ... benefits. The food ingredient market has numerous players ... such as Vital Force Technology (VFT). VFT ... than 4,000 energetic patterns, all tested to produce ...
(Date:7/31/2014)... , July 31, 2014 Nearly 20,000 ... th Annual Meeting & Clinical Lab Expo in ... meeting featured never-before-seen breakthroughs in diagnostic research and technology ... they need. As of Wednesday, July 30, ... AACC Annual Meeting & Clinical Lab Expo, with more ...
(Date:7/31/2014)... through organs and even the entire body to visualize ... structures has been a long-time dream of biologists. A ... in the journal Cell has now made ... opaque organs, bodies, and human tissue biopsies transparent, while ... could pave the way for a better understanding of ...
(Date:7/31/2014)... July 31, 2014 The SNIS Foundation ... $25,000 to fund a translational research project.  The ... the gift was presented at the Society of ... in Colorado Springs, CO. ... approaches to neurovascular conditions, SNIS formed the SNIS ...
Breaking Biology Technology:Functional Ingredient Manufacturer – Vital Force Technology Infuses Raw Materials & Ingredients with Subtle Energy Formula 2Research on Digital Health, Alzheimer's, Ebola Draws Nearly 20,000 Attendees to 2014 AACC Annual Meeting & Clinical Lab Expo 2Research on Digital Health, Alzheimer's, Ebola Draws Nearly 20,000 Attendees to 2014 AACC Annual Meeting & Clinical Lab Expo 3See-through organs and bodies will accelerate biomedical discoveries 2SNIS Foundation Bestows First Grant Award For Cutting-Edge NeuroInterventional Research 2SNIS Foundation Bestows First Grant Award For Cutting-Edge NeuroInterventional Research 3
... , , SAN ... (NYSE: SAI ) announced today that Anthony Hess, Ph.D., ... Health Solutions BU (HSBU) effective Aug. 3. Hess will ... and commercial health customers, including the Departments of Defense, Health and ...
... PERTH, Australia, July 16 Dow AgroSciences LLC, a wholly owned ... and NemGenix, a Perth based biotechnology company, announced today a newly ... , , The collaboration will ... Financial terms of the agreement were not disclosed. , ...
... , COSTA MESA, Calif., July 16 Oxygen Biotherapeutics, ... on the first $5 million financing tranche with the Vatea Fund, Segregated ... , For additional details on the agreement, please ... which is available on the SEC website at www.sec.gov and through the ...
Cached Biology Technology:Anthony Hess to Lead SAIC Health Solutions Business Unit 2Anthony Hess to Lead SAIC Health Solutions Business Unit 3Dow AgroSciences, NemGenix Establish New Collaboration in Plant Biotechnology 2
(Date:7/31/2014)... lurks beneath many of the roughly 156,000 gas ... is corrosion in parts of underground gas storage ... contamination of groundwater, a source of drinking water. ... have reported many rapidly corroding gas storage tank ... generally associated with use of gasoline-ethanol blends and ...
(Date:7/31/2014)... make a rational choice to be liberal or conservative? ... a matter of genetics?, Two political scientists from the ... say that neither conscious decision-making nor parental upbringing fully ... right. , A growing body of evidence shows that ... of political differences, the researchers say in the latest ...
(Date:7/31/2014)... known as the Rim Fire was in full fury, ... when it entered the backcountry of Yosemite National Park ... inside the park, the battle began to turn, enacting ... drought can combine to fuel large, severe fires. , ... encountered lands where fire had been used as a ...
Breaking Biology News(10 mins):NIST corrosion lab tests suggest need for underground gas tank retrofits 2Scientists find growing consensus: Political attitudes derive from body and mind 2The Rim Fire 1 year later: A natural experiment in fire ecology and management 2The Rim Fire 1 year later: A natural experiment in fire ecology and management 3The Rim Fire 1 year later: A natural experiment in fire ecology and management 4The Rim Fire 1 year later: A natural experiment in fire ecology and management 5
... are a major cause of disability or premature death in ... already suffered one fragility fracture; they are at twice the ... have not fractured. Nevertheless health care systems around ... leaving them exposed to debilitating and life-threatening secondary fractures. ...
... to 20 percent of veterans returning from Afghanistan and Iraq ... that nearly half these veterans may have a problem so ... it. A new study conducted by Charles W. Wilkinson, Elizabeth ... R. Peskind, all of the VA Puget Sound Health Care ...
... YORK , April 22, 2013 ... report is available in its catalogue: ... Opportunities, 2018 http://www.reportlinker.com/p01162444/India-Biometrics-Market-Forecast-and-Opportunities-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Security_Systems ... new and progressive products in ...
Cached Biology News:New review sets international standards for best practice in fracture liaison services 2Nearly half of veterans found with blast concussions might have hormone deficiencies 2Nearly half of veterans found with blast concussions might have hormone deficiencies 3India Biometrics Market Forecast and Opportunities, 2018 2India Biometrics Market Forecast and Opportunities, 2018 3India Biometrics Market Forecast and Opportunities, 2018 4India Biometrics Market Forecast and Opportunities, 2018 5India Biometrics Market Forecast and Opportunities, 2018 6
Phospho-SEK1/MKK4 (Thr261) Antibody...
Rabbit polyclonal to Warfarin ( Abpromise for all tested applications). Antigen: Chemical / Small Molecule conjugated to KLH...
HSD17B3 Immunogen: HSD17B3 (NP_000188, 29 a.a. ~ 120 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Rabbit polyclonal to 13,14 dihydro 15 keto Prostaglandin E2 ( Abpromise for all tested applications)....
Biology Products: